Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Cabaletta Bio Inc (CABA)

Cabaletta Bio Inc (CABA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Cabaletta Bio Inc 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104 USA

www.cabalettabio.com P: 267-759-3100

Description:

Cabaletta Bio Inc. is a clinical stage biotechnology company. It is focused on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. The company's product pipeline consists of DSG3-CAART, DSG3/1-CAART, MuSK-CAART and FVIII-CAART which are in clinical stage. Cabaletta Bio Inc. is based in Philadelphia, United States.

Key Statistics

Overview:

Market Capitalization, $K 579,914
Enterprise Value, $K 386,674
Shares Outstanding, K 46,805
Annual Sales, $ 0 K
Annual Net Income, $ -67,680 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -20,890 K
EBIT, $ -74,670 K
EBITDA, $ -74,060 K
60-Month Beta 2.52
% of Insider Shareholders 12.33%
Float, K 41,034
% Float 87.67%
Short Volume Ratio 0.52

Growth:

1-Year Return 1.23%
3-Year Return 29.47%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.46 on 03/21/24
Latest Earnings Date 05/09/24 [--]
Earnings Per Share ttm -1.65
EPS Growth vs. Prev Qtr -24.32%
EPS Growth vs. Prev Year 11.54%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

CABA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -40.83%
Return-on-Assets % -37.86%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 2.29
Book Value/Share 5.51
Interest Coverage -2.52
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar